Splenic cDC1 efferocytosis and cross-presentation to CD8 T cells are promoted by GPR34 and lysophosphatidylserine
Journal of Experimental Medicine · 2026
DOI: 10.1084/jem.20250887 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Experimental Medicine, 2026. Verfasst von Hanson Tam und 4 weiteren Autor:innen. Beteiligte Einrichtung: Howard Hughes Medical Institute, University of California, San Francisco , San Francisco, CA, USA. Hauptthemen laut MEDLINE: Dendritic Cells, Lysophospholipids, CD8-Positive T-Lymphocytes, Phagocytosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIAID NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
Spleen conventional dendritic cells type 1 (cDC1) take up apoptotic cells (AC) and cross-present associated antigens to CD8 T cells. The receptors promoting AC uptake are incompletely defined. Here, we tested the function of GPR34, a receptor that responds to the phosphatidylserine (PS) catabolite lysoPS. GPR34 deficiency led to reduced AC uptake by cDC1 but not cDC2 or macrophages. Uptake of soluble antigen or heat-killed bacteria was unaffected, whereas uptake of eryptotic RBCs was reduced. Using AC harboring OVA, activation and proliferation of OT-I T cells were compromised in GPR34-deficient mice. Reciprocally, GPR34 overexpression led to enhanced AC uptake and OT-I proliferation. The enzymes PLA1A and ABHD16A have been implicated in generating lysoPS that can act on GPR34. PLA1A but not ABHD16A deficiency was associated with a reduced OT-I response to AC-associated OVA. In conclusion, we identify a receptor requirement for cDC1 efferocytosis and cross-presentation and suggest a model where PLA1A catabolizes PS on AC to generate GPR34 ligands.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Howard Hughes Medical Institute, University of California, San Francisco , San Francisco, CA, USA.
- Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA, USA.
- Medical Scientist Training Program, University of California, San Francisco , San Francisco, CA, USA.
- Biomedical Sciences Graduate Program, University of California, San Francisco , San Francisco, CA, USA.
ORCID-Profile: Hanson Tam, Haolin Shen, Ying Xu, Jinping An, Jason G Cyster
Förderung
- NCI NIH HHS
- NIAID NIH HHS
- NIGMS NIH HHS
- NIH HHS
- Howard Hughes Medical Institute
- National Institutes of Health
Zitieren
APA
Tam, H., Shen, H., Xu, Y., An, J., & Cyster, J. G. (2026). Splenic cDC1 efferocytosis and cross-presentation to CD8 T cells are promoted by GPR34 and lysophosphatidylserine. Journal of Experimental Medicine. https://doi.org/10.1084/jem.20250887
Vancouver
Tam H, Shen H, Xu Y, An J, Cyster JG. Splenic cDC1 efferocytosis and cross-presentation to CD8 T cells are promoted by GPR34 and lysophosphatidylserine. Journal of Experimental Medicine. 2026. doi:10.1084/jem.20250887
BibTeX
@article{Tam2026,
author = {Tam, Hanson and Shen, Haolin and Xu, Ying and An, Jinping and Cyster, Jason G},
title = {Splenic cDC1 efferocytosis and cross-presentation to CD8 T cells are promoted by GPR34 and lysophosphatidylserine},
journal = {Journal of Experimental Medicine},
year = {2026},
doi = {10.1084/jem.20250887}
}
EUVIMED